Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Ozalp SH, Lohmann L, Giglhuber K, Haeussler V, Karenfort M, Hellwig K, Paul F, Bellmann-Strobl J, Otto C, Ruprecht K, Ziemssen T, Emmer A, Rothhammer V, Nickel F, Angstwurm K, Linker R, Laurent S, Warnke C, Jarius S, Kuhnke MK, Wildemann B, Wolff S, Seipelt M, Yalachkov Y, Retzlaff N, Zettl UK, Rommer P, Kowarik MC, Wickel J, Geis C, Huemmert MW, Trebst C, Senel M, Klotz L, Kleinschnitz C, Meuth SG, Aktas O, Berthele A, Ayzenberg I (2022)
Publication Type: Conference contribution
Publication year: 2022
Publisher: SAGE PUBLICATIONS LTD
City/Town: LONDON
Pages Range: 664-666
Conference Proceedings Title: MULTIPLE SCLEROSIS JOURNAL
APA:
Ringelstein, M., Asseyer, S., Lindenblatt, G., Fischer, K., Pul, R., Ozalp, S.-H.,... Ayzenberg, I. (2022). Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria. In MULTIPLE SCLEROSIS JOURNAL (pp. 664-666). Amsterdam, NL: LONDON: SAGE PUBLICATIONS LTD.
MLA:
Ringelstein, M., et al. "Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria." Proceedings of the 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam LONDON: SAGE PUBLICATIONS LTD, 2022. 664-666.
BibTeX: Download